SCHEMBL18924375

SCHEMBL18924375

CN(C)C(=O)c1ccc(-c2ccc(C#N)cc2)cc1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NSD2 O96028 1/20 0.51
CA1 P00915 2/20 0.50
CA2 P00918 2/20 0.50
ALDH1A1 P00352 1/20 0.48
HPGD P15428 1/20 0.48
SMN1; SMN2 Q16637 1/20 0.48
MMP3 P08254 2/20 0.48
PDK1 Q15118 1/20 0.48
PDK2 Q15119 1/20 0.48
PDK3 Q15120 1/20 0.48
PDK4 Q16654 1/20 0.48
ERN1 O75460 2/20 0.47
GSK3B P49841 2/20 0.46
MEN1 O00255 1/20 0.45
NPC1 O15118 1/20 0.45
KMT2A Q03164 1/20 0.45
GPR119 Q8TDV5 1/20 0.45
MMP2 P08253 3/20 0.44
MMP9 P14780 1/20 0.44
MMP8 P22894 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10933810 0.94 NSD2 (0.55) NSD2CA1CA2ALDH1A1HPGD
SCHEMBL22259646 0.89 NSD2 (0.51) NSD2CA1CA2ALDH1A1HPGD
SCHEMBL10626283 0.84 ALDH1A1 (0.64) ALDH1A1HPGDSMN1; SMN2PDK2ERN1
SCHEMBL30020530 0.81 ERN1 (0.43) NSD2ALDH1A1HPGDSMN1; SMN2PDK1
SCHEMBL24690186 0.81 ERN1 (0.43) NSD2ALDH1A1HPGDSMN1; SMN2PDK1
SCHEMBL13151106 0.81 NSD2 (0.54) NSD2CA1CA2ALDH1A1HPGD
SCHEMBL10058042 0.79 MAPT (0.66) CA1CA2ALDH1A1SMN1; SMN2MMP3
SCHEMBL5318807 0.77 ALDH1A1 (0.52) ALDH1A1HPGDSMN1; SMN2PDK2ERN1
SCHEMBL1004649 0.77 ALDH1A1 (0.73) ALDH1A1HPGDSMN1; SMN2PDK2ERN1
SCHEMBL20812229 0.76 TRPA1 (0.56) NSD2CA1CA2ALDH1A1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020150423-A1 METHODS FOR THE TREATMENT OF NEUROLOGICAL DISORDERS YUMANITY THERAPEUTICS, INC. (US) 2020-07-23 WO disclosed
US-9670142-B2 1,3-diaminocyclopentane carboxamide derivatives MERCK PATENT GMBH (DE) 2017-06-06 US disclosed